Acute ischemic stroke caused by Percheron artery occlusion after vertebral artery stent placement: a case report Authors: Yuxiang He, Shuning Diao, Taiying Li, Shengzhen Hou, Jinping Zhang Published: 2026 ABSTRACT AbstractBackgroundThe paramedian thalamic artery has four types of anatomical variants, among which type IIb is commonly referred to as the artery of Percheron (AOP). Occlusion of this artery typically results in bilateral paramedian thalamic infarction, with variable involvement of the rostral midbrain. We report a case of acute ischemic stroke caused by AOP occlusion, which is a rare complication of a neurointerventional procedure.Case presentationA 51-year-old male underwent stent placement due to severe stenosis with dissection of the V4 segment of the left vertebral artery. After the procedure, he presented with classic symptoms of AOP infarction, including acute altered consciousness and memory impairment. Magnetic resonance imaging (MRI) revealed bilateral paramedian thalamic and rostral midbrain infarction. He was diagnosed with an acute ischemic stroke caused by AOP occlusion and achieved a favorable outcome with symptomatic therapy, supportive care, and rehabilitation.ConclusionsThis case underscores that in patients who have stenosis with dissection undergoing neurointerventional procedures, heightened vigilance is required for the complication of distal embolization, and distal blood flow should be repeatedly assessed. When neurological deficits, such as altered consciousness, arise after the procedure, the possibility of AOP infarction should be considered, especially in patients with an anatomical variant of this artery. Timely MRI and treatments such as intravenous thrombolysis and endovascular therapy should be performed.Keywords: Artery of Percheron, Occlusion, Vertebral artery stenting, Acute ischemic stroke, Case report Background Large artery atherosclerotic stenosis is a common cause of ischemic stroke [1], and endovascular therapy represents an important revascularization strategy for symptomatic atherosclerotic stenosis at specific sites [2]. The artery of Percheron (AOP), found in approximately 4%–12% of the population, refers to a single paramedian thalamic artery that originates from the P1 segment of one posterior cerebral artery (PCA) and supplies the bilateral paramedian thalamic regions and the rostral midbrain [3]. Occlusion of this artery can result in the classic triad of altered consciousness, vertical gaze palsy, and memory impairment, as well as atypical symptoms such as aphasia and psychiatric disturbances [4]. Small vessel disease and microembolism are common causes of AOP infarction, whereas iatrogenic embolism associated with neurointerventional procedures is relatively uncommon. Herein, we report a case of AOP infarction following stent placement for stenosis with dissection of the vertebral artery, resulting in bilateral paramedian thalamic and rostral midbrain infarction, and we provide a review of the relevant literature. Case presentation A 51-year-old man was admitted on September 22, 2025, with a chief complaint of paroxysmal dizziness for more than one month. Pre-admission brain magnetic resonance imaging (MRI) revealed multiple acute infarctions in the left cerebellar hemisphere and brainstem. Digital subtraction angiography (DSA) showed severe stenosis of the V4 segment of the left vertebral artery, extracranial termination of the right vertebral artery, and a right fetal-type posterior cerebral artery. The patient had a history of cerebral infarction, hypertension, diabetes mellitus, coronary heart disease, and gastrointestinal bleeding associated with aspirin intake and had been on regular medication. The patient came to our hospital for further interventional therapy. The neurological examination was unremarkable, and a diagnosis of ischemic stroke was made. According to the guidelines, the patient received dual antiplatelet therapy of indobufen and clopidogrel at maintenance doses for more than 7 days. After thorough discussion with the patient and his family, cerebral angiography and left vertebral artery stent placement were performed under general anesthesia on September 23, 2025. The patient was placed in the supine position. After routine disinfection and draping, the right femoral artery was punctured using the Seldinger technique, and an arterial sheath (8F, Terumo) was placed. Systemic heparinization was then administered with an initial bolus of 3000 IU. Under the guidance of a Radifocus hydrophilic guidewire (0.035” × 150 cm, Terumo), a Ballast long vascular sheath (6F × 90 cm, Balt USA, LLC) and a Tempo multipurpose catheter (5F × 125 cm, Cordis) were coaxially advanced to the left subclavian artery. Angiography confirmed a long-segment severe stenosis with focal dissection of the V4 segment of the left vertebral artery (Fig. 1A, B). Under the guidance of the hydrophilic guidewire, a Sofia intermediate catheter (5F × 115 cm, MicroVention) was advanced to the V4 segment. Under digital subtraction roadmap guidance, a Synchro2 microguidewire (0.014” × 300 cm, Stryker) was carefully passed through the stenotic segment to the midsegment of the basilar artery. Along the microguidewire, a SacSpeed balloon (2.5 mm × 15 mm, Achieva Medical) was advanced to the site of stenosis with dissection to perform balloon angioplasty (Fig. 1C). After balloon angioplasty, angiography showed the stenosis was reduced and the dissection was no longer visualized. Subsequently, a Rebar 18 microcatheter (0.021” × 153 cm, Medtronic) was advanced over the microguidewire to the midsegment of the basilar artery. An EP2 stent (4.0 mm × 23 mm, Cerenovus) was advanced via the microcatheter to the stenotic site and deployed after precise positioning (Fig. 1D). Angiography was performed immediately and at 10 and 20 minutes after stent deployment, demonstrating good stent position and satisfactory wall apposition, with a residual stenosis of approximately 20%. Antegrade flow achieved a modified Thrombolysis in Cerebral Infarction (mTICI) grade 3, and no plaque recoil or distal embolization was observed (Fig. 1E, F). 7 mL of tirofiban hydrochloride and sodium chloride injection was slowly administered via intra-arterial bolus, followed by continuous intravenous infusion at a rate of 10 mL/h via a syringe pump. The long vascular sheath was withdrawn, and the right femoral artery puncture site was sealed using a vascular closure device, followed by a local pressure dressing. The procedure was then concluded. DSA during vertebral artery stenting. (A, B) Anteroposterior and lateral views of the posterior circulation showing stenosis with dissection of the V4 segment of the left vertebral artery (yellow arrows). (C) Balloon angioplasty. (D) Stent deployment (yellow arrows indicate the marker bands at both ends of the stent). (E, F) Postprocedural anteroposterior and lateral views of the posterior circulation Emergence from anesthesia was uneventful. However, the patient remained stuporous at 3 h after the procedure, could barely open eyes to verbal stimuli, and showed withdrawal to painful stimuli in all extremities, with no bilateral pathological reflexes. Cerebral hyperperfusion syndrome (CHS) was considered, and the patient was treated with intravenous urapidil hydrochloride for blood pressure control, mannitol for intracranial pressure reduction, and other medications such as methylprednisolone sodium succinate. On the following day, the patient remained stuporous with dysarthria, grade 3 muscle strength in all four limbs, and positive bilateral pathological reflexes. The National Institutes of Health Stroke Scale (NIHSS) score was 15 (level of consciousness: 2, left arm motor: 2, right arm motor: 2, left leg motor: 2, right leg motor: 2, best language: 3, dysarthria: 2), and the modified Rankin Scale (mRS) score was 5. Diffusion-weighted imaging (DWI) sequence of urgent brain MRI showed symmetrical restricted diffusion in the bilateral paramedian thalamic regions (Fig. 2A, B), along with a V-shaped area of restricted diffusion in the rostral midbrain (Fig. 2C), consistent with AOP infarction. The patient was diagnosed with AOP occlusion due to atheroembolism or thromboembolism. Given that the time window for intravenous thrombolysis, intra-arterial thrombolysis, and mechanical thrombectomy had been exceeded, and the patient had a recent history of gastrointestinal bleeding with mild anemia, which increased the risk of bleeding complications from thrombolysis, neither intravenous thrombolysis nor endovascular therapy was performed. Brain MRI on postoperative day 1. (A, B) MRI-DWI showing acute infarction in the bilateral paramedian thalamic regions (yellow arrows). (C) MRI-DWI showing the midbrain “V” sign of the AOP infarction (yellow arrows) The treatment regimen was adjusted as follows. Tirofiban infusion was discontinued. Indobufen tablets (0.2 g twice daily) and clopidogrel bisulfate tablets (75 mg once daily) were administered for antiplatelet aggregation. Atorvastatin calcium tablets (20 mg nightly) were given for lipid-lowering. Butylphthalide and sodium chloride injection (100 mL twice daily), edaravone and dexborneol concentrated solution for injection (15 mL twice daily), and urinary kallidinogenase for injection (0.15 PNA units once daily) were used to scavenge oxygen free radicals and improve collateral circulation. In addition, symptomatic supportive care and rehabilitation therapy were also provided. On postoperative day 15, the patient was alert, with bilateral ptosis, mild gait instability, mild dysarthria, and memory impairment. Muscle strength in all four limbs was grade 4+, and bilateral pathological reflexes were negative. The NIHSS score was 2, and the mRS score was 2. After treatment, the patient was discharged on October 23, 2025, with complete resolution of bilateral ptosis and slight improvement of other symptoms compared with postoperative day 15. After discharge, the patient continued to take antiplatelet drugs, lipid-lowering drugs, and neurotrophic drugs as prescribed by the physician. At 4 months postoperatively, computed tomography angiography showed patent flow within the stent. No new cerebral infarction was observed, and the patient exhibited residual mild gait disturbance, mild dysarthria, and mild memory impairment. Figure 3 shows the timeline of the disease course and treatments. The timeline of the disease course and treatments Discussion The diagnosis of AOP infarction presents unique challenges. Because the diameter of this artery is typically less than 2 mm, conventional vascular imaging often fails to directly visualize its occlusion. Therefore, diagnosis requires a comprehensive evaluation of clinical symptoms and characteristic imaging features [5]. However, the clinical presentation of AOP infarction is diverse. Some patients may not fully exhibit the classic triad or may even present only with atypical symptoms such as diplopia, dysarthria, or ataxia [6, 7]. Consequently, current research consensus holds that brain MRI, particularly DWI sequences, is the important standard for diagnosing this condition [8, 9]. The characteristic imaging features are restricted diffusion in the bilateral paramedian thalamic regions, appearing hyperintense on DWI and hypointense on ADC. In patients with concurrent midbrain involvement, DWI also reveals a V-shaped hyperintensity in the paramedian midbrain at the level of the interpeduncular fossa, which is known as the midbrain “V” sign. A definitive diagnosis can be essentially made in patients with suspected AOP infarction if the characteristic imaging features are present. Previous studies have shown that when a unilateral fetal-type PCA is accompanied by ipsilateral hypoplasia of the P1 segment, the type IIa or IIb paramedian thalamic artery (i.e., the artery of Percheron) originates from the contralateral normal P1 segment [10]. In this case, cerebral angiography revealed a right fetal-type PCA with hypoplasia of the right P1 segment, providing important anatomical support for the presence of AOP. After the procedure, the patient remained stuporous. After improvement in the level of consciousness, marked memory impairment emerged, consistent with the classic clinical presentation of AOP infarction. More importantly, brain MRI revealed symmetrical restricted diffusion in the bilateral paramedian thalamic regions and the rostral midbrain, fulfilling the imaging criteria for AOP infarction. These findings collectively confirmed the diagnosis of AOP infarction. The two major pathophysiological mechanisms underlying AOP infarction are small vessel disease and microembolism [6]. Small vessel disease is characterized by arteriolosclerosis and lipohyalinosis. The resulting infarcts are usually multiple, scattered lacunar infarcts and usually do not present as an acute onset immediately after an interventional procedure. In this case, the patient had severe stenosis with a local dissection of the V4 segment. Compared to isolated stenotic lesions, dissection combined with stenosis carries a higher risk of embolism [11]. Intimal tear exposes subendothelial extracellular matrix components such as collagen and von Willebrand factor, which activate platelet adhesion, aggregation, and release reactions. When the tear extends to the adventitia, tissue factor is exposed and initiates the extrinsic coagulation pathway. Hemodynamically, reduced local shear stress at the site of the intramural hematoma formed by the dissection facilitates the aggregation of coagulation factors. Additionally, turbulent flow further promotes the formation of platelet-fibrin complexes, creating conditions predisposed to thrombus formation. Therefore, the most likely mechanism in this case was intraoperative manipulation caused the dislodgement of plaque or thrombus, which embolized to the AOP and led to acute ischemic stroke. Prior to diagnosing AOP infarction, we first conducted a systematic differential diagnosis of the possible etiologies of postoperative altered consciousness. CHS was the initial consideration. The pathophysiological mechanism of CHS is an abnormal increase of cerebral blood flow in the ischemia-reperfusion region following cerebrovascular revascularization surgery under chronic hypoperfusion, exceeding the metabolic demands of the brain tissue. Its main manifestations include headache, focal neurological deficits, seizures, and loss of consciousness [12]. Altered consciousness is one of the core manifestations of CHS. In our case, the timing of this symptom onset was consistent with the characteristics of CHS. Moreover, the patient had severe vertebral artery stenosis, providing a pathological basis for the development of CHS. Therefore, we initially considered a diagnosis of CHS. After treatment to control blood pressure and reduce intracranial pressure proved ineffective, and MRI clearly indicated a new acute cerebral infarction rather than vasogenic edema, the diagnosis of CHS was subsequently excluded. Other potential etiologies of altered consciousness were also systematically excluded. Contrast-induced encephalopathy can present with an altered level of consciousness, but its imaging feature is vasogenic edema rather than cytotoxic edema. And the symptoms are usually self-limiting, with most patients recovering spontaneously. Hypoperfusion-related cerebral infarction typically manifests as watershed infarction on imaging, whereas the patient’s infarct regions were confined exclusively to a single perforator territory. Moreover, the patient’s intraoperative and postoperative systolic blood pressure remained consistently ≥ 90 mmHg, which does not satisfy the hemodynamic criteria for hypoperfusion-related cerebral infarction. The injury or direct occlusion of the perforator ostium caused by interventional devices may also lead to acute cerebral infarction. For example, dislodgement of plaque or thrombus by the advancing balloon or stent occludes the perforator ostium, direct compression and occlusion of the perforator ostium by the balloon or stent struts, or direct injury to the perforator ostium by the guidewire. In the present case, the device was advanced no further than the midsegment of the basilar artery, which remained at a certain distance from the AOP, thus lacking the spatial prerequisite for perforator injury. In addition, the patient received general anesthesia management according to standard protocols, with induction and maintenance using clinically routine doses of anesthetics. After the procedure, anesthetic discontinuation and emergence were also carried out per the standard protocol. However, the symptoms did not significantly improve after the anesthetic agents were metabolized. Furthermore, the patient had no history of hepatic or renal disease. Postoperative hematological examinations, including blood glucose, serum electrolytes, and arterial blood gas analysis, revealed no significant abnormalities such as hypoglycemia, electrolyte disturbances, pulmonary encephalopathy, hepatic encephalopathy, or uremic encephalopathy that might affect anesthetic metabolism or cause altered consciousness. Therefore, delayed emergence from general anesthesia and metabolic encephalopathy were also excluded. Based on classic clinical symptoms, characteristic imaging features, and systematic differential diagnosis of other possible etiologies, the patient was ultimately diagnosed with AOP infarction. AOP infarction is relatively rare and lacks large-scale randomized controlled trial evidence or established clinical guidelines. In clinical practice, treatment generally follows the standard guidelines for acute ischemic stroke. Current research on AOP infarction indicates that intravenous rt-PA thrombolysis within the time window is the first-line treatment for acute AOP infarction, effectively improving outcomes and reducing disability levels [13, 14]. For patients who are ineligible for intravenous thrombolysis or have poor efficacy, endovascular therapy such as intra-arterial thrombolysis and mechanical thrombectomy may be considered. For example, Kamran et al. performed intra-arterial thrombolysis on a patient with bilateral thalamic and midbrain infarction caused by AOP occlusion, achieving complete recanalization of the AOP [13]. Given the extremely small diameter of the AOP, direct thrombectomy is not feasible. For patients with occlusion of proximal vessels, such as the basilar artery or the P1 segment of the PCA, mechanical thrombectomy may be considered. For instance, Matsushima et al. performed mechanical thrombectomy in a patient with AOP occlusion due to distal thrombus migration following occlusion of the top of the basilar artery, achieving complete recanalization of the AOP and immediate recovery of consciousness [15]. The time window for intravenous thrombolysis and endovascular therapy was the primary factor limiting the choice of treatment regimen in this case. The standard time window for intravenous thrombolysis is within 4.5 h after symptom onset. Under specific conditions, such as confirmation of salvageable brain tissue using multimodal imaging, it may be extended to 9 h or even 24 h. The standard time window for intra-arterial thrombolysis is within 6 h after symptom onset. And the standard time window for mechanical thrombectomy is also 6 h, but it can be extended up to 24 h after rigorous imaging evaluation [16, 17]. In this case, the time from symptom onset to the diagnosis of AOP infarction confirmed by brain MRI had exceeded 24 h, and the patient also had a recent history of gastrointestinal bleeding, significantly increasing the risk of symptomatic intracranial hemorrhage associated with thrombolysis. Moreover, the patient’s basilar artery and right P1 segments of the PCA were normal, with no indication for mechanical thrombectomy due to proximal vessel occlusion. Consequently, the patient did not receive intravenous thrombolysis or endovascular therapy. Therefore, early recognition is key to the treatment of AOP infarction. Studies have shown that the average time from symptom onset to imaging confirmation in patients with AOP infarction is 1.9 days, significantly exceeding the time window for intravenous thrombolysis or endovascular therapy [18]. This case highlights a key lesson for neurointerventionalists. In patients with the AOP, when new-onset neurological deficits, especially altered consciousness, vertical gaze palsy, and memory impairment, occur after posterior circulation endovascular intervention, AOP infarction should be considered immediately after rapid exclusion of other etiologies. Prompt brain MRI should be obtained to confirm the diagnosis, thereby gaining time for subsequent treatment to improve patient outcomes. Furthermore, to reduce the risk of this complication associated with neurointerventional procedures, adequate dual antiplatelet therapy should be administered preoperatively to inhibit thrombosis [19]. Gentle manipulation of guidewires and catheters, selection of relatively conservative balloon sizes, and avoidance of repeated high-pressure angioplasty may reduce disruption of the plaque or thrombus. Distal embolic protection devices, such as filters, may capture dislodged plaque or thrombotic debris. For patients with heavy plaque burden or high risk of thrombus embolization, their use may be considered when conditions permit [20]. In summary, acute ischemic stroke caused by AOP occlusion following vertebral artery stent placement is clinically rare. This case can enhance neurointerventionalists’ awareness of this complication and aid in the early differential diagnosis of postoperative acute altered consciousness caused by AOP occlusion, thereby preventing misdiagnosis as other etiologies. Furthermore, the patient’s characteristic MRI findings and classic clinical symptoms may serve as a reference for future cases. This case report also has some limitations. DSA is considered the reference standard for direct assessment of vascular occlusion. Because of the relatively small diameter of the AOP, DSA has limited capability to visualize it. Therefore, direct observation of AOP occlusion was not achieved via intraoperative DSA. After comprehensive exclusion of other etiologies, the diagnosis was made based on the combination of the patient’s highly specific imaging findings of AOP infarction and the classic clinical symptoms presented. If AOP occlusion had been directly observed by DSA, it would have further enhanced the reference value of this report. Additionally, a single case may not accurately reflect the independent risk factors of AOP infarction following a neurointerventional procedure. Nevertheless, we hope that this report may provide a reference for the clinical prevention, identification, and treatment of this complication. Conclusions This case suggests that rare AOP infarction can occur following vertebral artery stent placement. The characteristic MRI features are bilateral paramedian thalamic and rostral midbrain infarction, and classic symptoms are the triad of altered consciousness, vertical gaze palsy, and memory impairment. Neurointerventionalists should be vigilant about this complication. And if this complication occurs after the procedure, it should be identified early and treated promptly. Acknowledgements Not applicable. Abbreviations Artery of Percheron Digital Subtraction Angiography Magnetic Resonance Imaging Posterior Cerebral Artery Modified Thrombolysis in Cerebral Infarction Cerebral Hyperperfusion Syndrome National Institutes of Health Stroke Scale Modified Rankin Scale Diffusion-weighted Imaging Authors’ contributions YH: Writing−original draft, Writing−review & editing, Data curation, Investigation. SD: Writing−original draft. TL: Investigation. SH: Project administration. JZ: Writing−review and editing, Project administration, Supervision. Funding Not applicable. Data availability All data generated or analysed during this study are included in this published article. Declarations Ethics approval and consent to participate Not applicable. Consent for publication The patient has provided written informed consent for the use of all his clinical data to publish this study. Competing interests The authors declare no competing interests. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Data Availability Statement All data generated or analysed during this study are included in this published article.